Neuracle Performs China's First Commercial Invasive Brain-Computer Interface Surgery

Summary

Surgeons at Huashan Hospital in Shanghai implanted Neuracle Medical Technology's NEO device in a patient with hand-mobility loss from a decade-old spinal cord injury, marking the first surgery performed under China's National Medical Products Administration commercial approval for an invasive BCI (granted in March 2026). The coin-sized, battery-free device sits on the brain's surface rather than penetrating it, recording signals that a robotic glove translates into hand-grasping motion. The procedure captured stable, high-quality signals, with the patient recovering and vital signs stable afterward.